Organization · Venture Capital
Lightstone Ventures
Lightstone Ventures is a venture capital firm based in the United States, focusing on early-stage investments in biotech and medtech companies that develop innovative therapeutics and technologies. Founded in 2012, it aims to transform patient outcomes through strategic investments.
Overview
What Lightstone Ventures does
What Lightstone Ventures is
Lightstone Ventures is a venture capital firm based in the United States, focusing on early-stage investments in biotech and medtech companies that develop innovative therapeutics and technologies. Founded in 2012, it aims to transform patient outcomes through strategic investments.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 27, 2026
Official channels
Find Lightstone Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Lightstone Ventures as a funder
Investment thesis
Lightstone Ventures invests in early-stage biotech and medtech companies developing disruptive technologies that transform patient outcomes.
Focus narrative
Lightstone Ventures targets investments in the biotech and medtech sectors, specifically in companies that develop first-in-class drugs and groundbreaking medical technologies. Their investment strategy is thesis-driven, focusing on disruptive technologies across various disease areas, including central nervous system disorders, immunology, oncology, and ophthalmology. The firm seeks to partner with founders who leverage data analytics and scientific platforms to drive innovation.
Value beyond capital
Lightstone Ventures adds value to its portfolio companies through its extensive operational experience and industry connections. The firm provides strategic guidance, access to a network of experts, and support in navigating the complexities of the biotech and medtech landscapes. Their team is committed to helping founders achieve their vision and drive innovation in therapeutics.
Terms and economics
- Typical check
- $1,000,000–$50,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Series D · Growth Equity
- Regions
- Europe · Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
- Recorded notable exits
- Shoulder Innovations
Portfolio context
Notable portfolio companies include: Acceleron Pharma: A clinical-stage biopharmaceutical company focused on therapeutics for serious and rare diseases. Alchemab Therapeutics: Utilizes deep learning to develop novel drugs for hard-to-treat diseases by harnessing naturally protective antibodies. Allay Therapeutics: Pioneering ultra-sustained analgesic products for post-surgical pain management. Nimbus Therapeutics: Engaged in developing innovative therapeutics. Cala Health: Focused on transforming patient care through technology. Shoulder Innovations: A company dedicated to advancing shoulder surgery technologies. Fire1: Involved in developing innovative solutions in the healthcare space.
Capability profile
Lightstone Ventures as a publisher
Editorial focus
Lightstone Ventures focuses on investing in novel and disruptive technologies in the life sciences sector, particularly in biotech and medtech. The firm targets companies developing first-in-class drugs across various modalities, including small molecules, biologics, and cell and gene therapies, with a focus on CNS disorders, immunology, oncology, and ophthalmology. In medtech, they seek innovative ideas that merge technology, medicine, and consumer health, especially in personalized medicine and targeted therapeutics.
Audience value
Lightstone Ventures provides value by investing in high-impact therapeutics and technologies that aim to transform patient outcomes, supporting founders with innovative ideas and a commitment to improving healthcare.
Format and cadence
- Primary platform
- Lightstone Ventures
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Investors
- Sectors
- Biotech & Life Sciences
- Regions
- United States
Flagship work and coverage
Flagship properties
Lightstone Ventures operates the 65LAB program, a strategic investment in a Singapore-based incubator partnered with Evotec, aimed at growing a pipeline of investible therapeutic companies originating from research institutions in Singapore.
Notable coverage
Lightstone Ventures has been featured in various reputable publications such as Fierce Biotech, BioPharma Dive, and GeneOnline, highlighting their significant fundraising efforts and portfolio successes.
Common questions
What to know about Lightstone Ventures
Upseed classifies Lightstone Ventures under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.